Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)

Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)

Abstract Cancer survivors receiving doxorubicin may experience left ventricular ejection fraction (LVEF) decline during and following treatment; however, explanations for variations in decline beyond dosage differences, such as those related to socioeconomic status (SES), have not been fully examine...

Full description

Saved in:
Bibliographic Details
Main Authors: Arnethea L. Sutton, Nathaniel S. O’Connell, Alexander R. Lucas, Kristine C. Olson, Kerryn W. Reding, Vanessa B. Sheppard, Bonnie Ky, Kathryn J. Ruddy, Kathryn E. Weaver, W. Gregory Hundley
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Cardio-Oncology
Subjects:
Breast cancer
Left ventricular ejection fraction
Socioeconomic status
Social drivers of health
Online Access:https://doi.org/10.1186/s40959-025-00311-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40959-025-00311-y

Similar Items